Briakinumab

Briakinumab is a human monoclonal antibody developed for the treatment of rheumatoid arthritis, inflammatory bowel disease, and multiple sclerosis.

Category: Business > Healthcare > Pharmaceutical

News, Reviews & Offers

There are no posts for this page yet.